Home
News
Interviews
Companies
Videos
Subscribe
The
Latest
The Latest
News
Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
News
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
News
Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
News
Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026
More Articles
FEATURED
Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms
News
Filament Health Announces Interim Results From Phase I Clinical Trial At The University Of California San Francisco
News
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study
Trending
#
News
Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
#
News
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E Trial
#
News
Optimi Health Granted Natural Health Product Site Licence By Health Canada
#
News
Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder
#
News
MindMed Publishes Report by Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy
Companies
#
ATAI Life Sciences
NEO
NASDAQ
ATAI
CSE
TSXV
Private Company
Non-Profit
#
Compass Pathways
NEO
NASDAQ
CMPS
CSE
TSXV
Private Company
Non-Profit
#
Algernon Pharmaceuticals
NEO
NASDAQ
CSE
AGN
TSXV
Private Company
Non-Profit
#
Mind Medicine (MindMed)
NEO
MMED
NASDAQ
MNMD
CSE
TSXV
Private Company
Non-Profit
#
Cybin Inc.
NEO
CYBN
NASDAQ
CSE
TSXV
Private Company
Non-Profit